Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C N R S )	PARIS
UNIVERSITE DE STRASBOURG	4 RUE BLAISE PASCAL CS 90032 STRASBOURG CEDEX 67081
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)	101 RUE DE TOLBIAC PARIS 75013

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF

• 2014 Application Filing Year
• A61K Class
• 14144 Applications Filed
• 11600 Patents Issued To-Date
• 82.02 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
AUBORG, Patrick	Le Kremlin Bicetre, FR	3	10
# of filed Patents : 3 Total Citations : 10
BOUGNERES, Pierre	Le Kremlin Bicetre, FR	15	46
# of filed Patents : 15 Total Citations : 46
CRYSTAL, Ronald G	New York, US	67	1018
# of filed Patents : 67 Total Citations : 1018
PUCCIO, Helene Monique	Illkirch, FR	5	53
# of filed Patents : 5 Total Citations : 53

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 4 Citation Count
• A61K Class

• 38.16 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jul 28, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2016/0024,526

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

---

Abstract

---

The present invention relates to a method for preventing or treating cardiomyopathy due to energy failure in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a vector which comprises a nucleic acid sequence of a gene that can restore energy failure. More particularly, the invention relates to a method for preventing or treating a cardiomyopathy associated with Friedreich ataxia in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a vector which comprises a frataxin (FXN) encoding nucleic acid.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.